Cripto-1 (TDGF1) is a multifunctional signaling factor that stimulates cellular effects, including proliferation, migration, survival, epithelial-to-mesenchymal transition, and angiogenesis, to regulate embryogenesis, tissue homeostasis, and tumorigenesis. Those cell behaviors are also associated with implantation of the embryo into the uterine wall, and this led us to investigate the role of embryo-derived Cripto in embryo attachment and implantation. In this study, we show that Cripto and its signaling mediator GRP78 are uniquely localized to embryo implantation sites. We knocked down Cripto expression specifically in trophoblast cells and found that this resulted in a corresponding decrease in the levels of its downstream signaling mediators, phosphorylated (phospho-)SMAD2, phospho-SRC, phospho-extracellular signal-regulated kinase, and phospho-AKT, which are also known mediators of embryo implantation. We then transplanted Cripto knockdown and control embryos into uteri of pseudopregnant female mice and found that embryos with Cripto-depleted trophoblast cells had dramatically impaired capacity to attach to the uterine wall when compared with controls. This loss of appropriate embryo attachment following Cripto knockdown in trophoblast cells was associated with abnormally enlarged implantation sites that were almost completely devoid of microvessels. A role for Cripto in embryo implantation was further supported by our demonstration that attachment of trophoblast-derived spheroids to endometrial cells in vitro was stimulated by Cripto treatment and diminished by treatment with either of two mechanistically distinct Cripto blocking agents. Collectively, our findings identify Cripto as a novel and critical embryo attachment factor and suggest that modulation of Cripto signaling may have significant therapeutic potential for the treatment of infertility and other related disorders. (Endocrinology 159: 1793(Endocrinology 159: -1807(Endocrinology 159: , 2018 
I mplantation of the embryo into the uterine wall is a prerequisite for a successful pregnancy. Recognition signals generated by the conceptus constitute a key part of the implantation process because they stimulate the establishment of a uterine microenvironment that supports embryo attachment and invasion. Notably, it is within the peri-implantation period that most embryonic deaths occur, and many miscarriages are attributed to failure of the conceptus to produce the signals essential for the appropriate uterine response (1) .
Cripto (Cripto-1, TDGF1) is a small glycosylphosphatidylinositol-anchored/secreted signaling protein related to members of the epidermal growth factor (EGF) family. Cripto plays essential roles during vertebrate embryogenesis (2) (3) (4) (5) , but to our knowledge its specific involvement in embryo implantation has not yet been investigated (6) (7) (8) (9) . Cripto modulates several transforming growth factor (TGF)-b superfamily members that signal via the Smad2/3 pathway, including Nodal, which requires Cripto as a coreceptor (3) . Soluble, secreted forms of Cripto can also activate SRC/mitogen-activated protein kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K)/AKT pathways (10) .
We previously identified GRP78, an endoplasmic reticulum chaperone and regulator of the unfolded protein response (11) , as a Cripto-binding protein and signaling partner (12, 13) . We subsequently reported that GRP78 forms a signaling complex with Cripto at the cell surface and that this interaction is required for Cripto regulation of TGF-b superfamily member signaling as well as for its stimulation of the SRC/MAPK/PI3K/AKT pathways (4, 10, 12, 14) .
Cripto has been broadly implicated as a regulator of stem cell function and tumorigenesis (6) (7) (8) (9) and, similar to other EGF family members, it can stimulate cell proliferation, migration, angiogenesis, invasion, cell survival, and epithelial-to-mesenchymal transition (15, 16) . Given the importance of these processes in embryomaternal recognition and embryo implantation, we investigated whether embryo-derived Cripto plays a role in embryo attachment and the establishment of pregnancy. Our results suggest that in addition to its established critical role during development of the embryo proper, Cripto is a critical embryo attachment signal originating from embryonic trophoblast cells.
Materials and Methods

Animals
To examine Cripto expression during pregnancy, sexually mature, cycling female C57BL/6 mice (7 to 9 weeks old) were mated with C57BL/6 male mice. The next morning, the females were monitored for vaginal plug [indicating day 0.5 of pregnancy, or embryonic day (E)0.5]. Uteri were isolated at the indicated days of pregnancy and further analyzed. All protocols for animal breeding, handling, and experimental procedures were approved by the Institutional Animal Care and Use Committee of the Salk Institute and the agricultural research organization.
Trophoblast-specific Cripto silencing
Blastocysts with trophoblast-targeted silencing of Cripto were generated as described previously (17, 18) . Briefly, wildtype ICR females were superovulated by subcutaneous injection of pregnant mare's serum gonadotropin (Sigma-Aldrich, Rehovot, Israel) (5 U) followed 48 hours later by intraperitoneal injection of human chorionic gonadotropin (Sigma-Aldrich) (5 U) and then mated with wild-type ICR males. Morulas and blastocyst stage embryos were collected from the females at E2.5 and then incubated in KSOM medium to obtain expanded blastocysts. Zona pellucida was removed in acidic Tyrode's solution. Next, 15 to 20 embryos were incubated with either control lentiviruses harboring scrambled short hairpin RNA (shRNA) sequence or short hairpin Cripto (shCripto) viruses (12) in KSOM medium for 6 hours. The transduced blastocysts were washed four times and then transferred into the uteri of pseudo-pregnant ICR females generated after mating with vasectomized ICR males. Ten blastocysts were transplanted into each mouse using a nonsurgical embryo transfer kit (ParaTechs, Lexington, KY).
Validation of Cripto silencing
Blastocysts from control and Cripto-silenced groups were stained by whole-mount incubation with antibodies raised against Cripto, stained with species-specific secondary antibodies, counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI; Invitrogen, Carlsbad, CA), and subsequently mounted in mineral oil and imaged using spinning disk 386 confocal microscope (Cell Observer SD; Zeiss, Oberkochen, Germany).
Additionally, total RNA from implantation site at day 4.5, isolated as described previously, was extracted using RNeasy mini columns (Qiagen, Hilden, Germany) and converted into complementary DNA (cDNA) with a high-capacity cDNA kit (Applied Biosystems, Foster City, CA), according to the manufacturer's guidelines. The cDNAs were used for quantitative polymerase chain reaction (PCR) analysis using Cripto-specific primers as described later in the real-time PCR analysis section.
For validation of Cripto protein silencing, proteins were extracted from implantation site at day 4.5, isolated as describe previously, for western blot analysis. Proteins were isolated in radioimmunoprecipitation assay buffer using homogenizer, and suspended in Laemmli loading buffer [125 mM Tris (pH 6.8), 4% sodium dodecyl sulfate, 10% glycerol, 0.006% bromophenol blue, and 2% b-mercaptoethanol]. The proteins were then separated on a 10% acrylamide gel, followed by their transfer to a nitrocellulose membrane. After blocking with 5% skimmed milk, the membranes were incubated with primary antibodies at 4°C (13) (dilution for antiCripto, 1:1000; dilution for anti-b-actin, 1:2000; Thermo Scientific, Rockford, IL) and then with the secondary antibodies for 1 hour at room temperature (RT; dilution for secondary antibodies, 1:5000; Jackson ImmunoResearch Laboratories, West Grove, PA). The immunoreactive bands were detected by enhanced chemiluminescence (Amersham, Little Chalfont, United Kingdom).
On E4.5, mice were intravenously injected with Evans blue (Sigma-Aldrich) at 1% weight-to-volume ratio in saline (100 mL) (19) . Evans blue binds serum proteins and accumulates around the implanting embryos (19) . Mice were euthanized 10 minutes after injection, and implantation sites were counted. A mouse was considered pregnant upon the appearance of at least one implantation site. Isolated uteri or implantation sites were taken to different analysis described herein.
Evaluation of embryo attachment
On E4.5, mice were intravenously injected with Evans blue (Sigma-Aldrich) at 1% volume-to-weight ratio in saline (100 mL) (19) . Evans blue binds serum proteins and accumulates around the implanting embryos (19) . Mice were then euthanized 10 minutes after injection, and implantation sites were counted. Then, a 1-mL syringe with 30-gauge needle was inserted into the cervix and the embryos were washed from both uterine horns with phosphate-buffered saline (PBS; Bilogical Industries, Bet HaEmek, Israel) and detected using binicular. A female was considered pregnant upon the appearance of at least one implantation site. The percentage of attachment was calculated as the nonwashed embryo number relative to the total number of implantation sites counted before uterine wash.
Histology
Uterine sections containing embryo implantation sites were fixed in 4% paraformaldehyde (PFA; Sigma-Aldrich) and embedded in paraffin. For morphological analysis, tissues were sectioned serially at a thickness of 4 mm and stained with hematoxylin and eosin. Sections were histologically examined for embryo development and any possible gross endometrial or trophoblast cell abnormalities using E600 eclipse microscopy (Nikon, Tukyo, Japan). Implantation size quantification was performed using ImageJ software.
KI67 and terminal deoxynucleotidyltransferasemediated dUTP nick end labeling staining
Uterine sections containing embryo implantation sites were fixed in 4% PFA and embedded in paraffin. For KI67 staining, sections underwent antigen retrieval in citrate (pH 6.0) buffers in a pressure cooker at 125°C for 3 minutes. Antigens were washed, blocked with 20% normal horse serum, permeabilized with 0.2% Triton X-100 in PBS for 1.5 hours at RT, and then incubated overnight with rabbit anti-KI67 (Table 1) . Next, slides were washed and incubated with secondary anti-rabbit antibodies conjugated to biotin and diluted 1:100 in 2% normal horse serum in PBS for 1.5 hours at RT. Slides were then washed in PBS and incubated in Cy3-or Cy2-conjugated streptavidin (Jackson ImmunoResearch Laboratories), diluted 1:150 in PBS for 45 minutes, at RT followed by exposure to diaminobenzidine (Sigma-Aldrich). Slides were counterstained with hematoxylin and subsequently mounted. All slides were imaged using an Olympus SZX-RFL2 zoom stereomicroscope. Cells undergoing apoptosis were detected by terminal deoxynucleotidyltransferasemediated dUTP nick end labeling (TUNEL) staining (ApopTag; Merck Millipore, Burlington, MA) according to the manufacturer's instructions.
Immunofluorescence
Uterine horn, implantation sites, or embryos were fixed in 4% PFA. Uterine horns were sectioned serially at a thickness of 4 mm. Immunofluorescence was performed on embryos or deparaffinized sections washed in tap water and PBS. Blocking of nonspecific binding sites was obtained by incubating the sections for 30 minutes in 3% fetal calf serum in PBS. Sections were then incubated overnight at 4°C with the first antibody (Table 1) . Then, sections were washed with PBS and immunoreacted with the relevant secondary antibody for 1 hour at RT ( Table 1 ). The samples were washed three times with PBS and visualized using a Zeiss LSM 710 confocal microscope (Zeiss). All images were taken under identical conditions.
Immunohistochemistry
Uterine sections containing embryo implantation sites were fixed in 4% PFA and embedded in paraffin. Then, sections underwent antigen retrieval in citrate (pH 6.0) or EDTA (pH 8.0) buffers in a pressure cooker at 125°C for 3 minutes. Antigens were washed, blocked with 20% normal horse serum, permeabilized with 0.2% Triton X-100 in PBS for 1.5 hours at RT, and then incubated overnight with primary antibodies (Table 1) . Next, slides were washed and incubated with secondary antibodies, conjugated to biotin against the appropriate species (Table 1) , and diluted 1:100 in 2% normal horse serum in PBS for 1.5 hours at RT. Slides were then washed in PBS and incubated in Cy3-or Cy2-conjugated streptavidin (Jackson ImmunoResearch Laboratories), diluted 1:150 in PBS for 45 minutes, at RT. Then, slides were washed in PBS and incubated in avidin/biotin complex (Vectastatin; Vector Laboratories, Burlingame, United Kingdom) in PBS for 1.5 hours at RT, followed by exposure to diaminobenzidine (Sigma-Aldrich). Slides were counterstained with hematoxylin and subsequently mounted. All slides were imaged using a fluorescent Olympus SZX-RFL2 zoom stereomicroscope.
Western blot analysis
To examine Cripto expression during pregnancy, sexually mature, cycling female C57BL/6 mice (7 to 9 weeks old) from Harlan Laboratories (San Diego, CA) were mated with C57BL/ 6 male mice. The next morning, the females were monitored for vaginal plug (indicating day 0.5 of pregnancy) and uteri were isolated at the indicated days of pregnancy. Then, western blot analysis was performed on proteins isolated from uteri at the indicated time points in radioimmunoprecipitation assay buffer using homogenizer, and suspended in Laemmli loading buffer [125 mM Tris (pH 6.8), 4% sodium dodecyl sulfate, 10% glycerol, 0.006% bromophenol blue, and 2% b-mercaptoethanol). Then, western blot analysis was performed as described previously.
Gene expression analysis
Total RNA from uteri was extracted using RNeasy mini columns (Qiagen), according to the manufacturer's guidelines. RNA was converted into cDNA with a high-capacity cDNA kit (Applied Biosystems), according to the manufacturer's guidelines using oligo(dT) and Moloney murine leukemia virus reverse transcription. The cDNAs were used for quantitative PCR analysis. All quantitative PCRs were carried out on a StepOnePlus (Applied Biosystems), using the Absolute Blue quantitative PCR master mix (Thermo Scientific, Waltham, MA) with SYBR Green. Reaction protocols had the following format: 15 minutes at 95°C for enzyme activation, followed by 40 cycles of 15 seconds at 95°C, 30 seconds at 60°C, and 15 seconds at 72°C, at the end of which fluorescence was measured with a Rotor-Gene. SYBR Green-I assays also included a melt curve at the end of the cycling protocol, with continuous fluorescence measurement from 65 to 99°C. All reactions contained the same amount of cDNA, 10 mL of Absolute Blue quantitative PCR master mix, primers for the indicated genes (Supplemental Table 1 ), and UltraPure PCR-grade water (Biological Industries) to a final volume of 20 mL. Each realtime PCR included a no-template control, in duplicate. Relative expression levels (DDCt) were calculated by normalizing to hypoxanthine guanine phosphoribosyl transferase. Primers were designed using the primer3 Web site (http://frodo.wi.mit.edu/primer3).
In vitro attachment assay
The in vitro model for implantation was performed as described previously (20) . Briefly, Jeg3 cells, a human trophoblast cell line, were cultured in a humid atmosphere containing 5% CO 2 at 37°C on a shaker for 24 hours. The resulting spheres were stained using calcein-AM (BD Biosciences, Franklin Lakes, NJ) and were monitored using G-BOX gel imager (Syngene, Cambridge, UK) to test their viability and to count them. Then, (Table 1) , and the cocultures were maintained for 6 hours at 37°C. At the end of incubation, nonadherent spheroids were removed by washing the culture plates and the plates were examined using a G-BOX gel imager (SYNGENE, Cambridge, United Kingdom). The number of tightly attached spheroids in each well was counted using Whole-mount embryo high-resolution episcopic microscope scanning
Implantation sites were fixed in 4% PFA and then were gradually dehydrated in methanol and embedded in 2-hydroxyethyl methacrylate solution (JB-4; Polysciences, Warrington, PA) containing eosin and acridine orange dyes as previously described (21, 22) for 24 hours on a revolving shaker at RT. To achieve maximum magnification, the implantation sites were mounted in a vertical orientation, and blocks were cut using the high-resolution episcopic microscope (HREM) system (Indigo Scientific, Baldock, UK). Images of .1500 sections (1.5 mm thick) were captured, stacked, and processed using Fiji software (23) , and three-dimensional reconstruction was performed using Amira software (FEI, Hillsboro, OR).
Statistical analysis
Each experiment was carried out at least three times, with at least three to four mice at each time point. Data points are presented as mean 6 standard error. Statistical significance was calculated using a Student two-tailed unpaired t test (Microsoft Excel).
Results
Cripto is expressed by the embryo and uterus during the peri-implantation stage
Immunostaining of hatched blastocysts revealed that Cripto is expressed by both the trophectoderm cells and the inner cell mass (Fig. 1Aa-c) . Staining E4.5 uterine sections with anti-Cripto antibody revealed that Cripto is localized both to blastocysts undergoing attachment as well as to the uterine luminal epithelium and the adjacent subepithelial stromal cells (Fig. 1Ad-f) . Western blot analysis of E4.5 mouse uteri revealed that the expression of Cripto protein was restricted to the embryo implantation sites and was not expressed in interimplantation sites (Fig. 1B) .
Expression of a Cripto shRNA in trophoblast cells reduces levels of Cripto and activated forms of its downstream signaling mediators Attachment of the embryo to the uterine wall is a prerequisite for successful implantation. To test the requirement of Cripto for embryo implantation, we knocked down Cripto expression via lentiviral delivery of a Cripto shRNA into trophoblast cells. Infecting embryos with lentiviral particles harboring Cripto shRNA led to a substantial decrease of .50% in both Cripto messenger RNA and protein levels relative to control specifically in the trophoblast cells (Supplemental Fig. 1 ).
Because Cripto triggers phosphorylation and activation of extracellular signal-regulated kinase (ERK), SRC, and AKT as well as SMAD2 in presence of ligands such as Nodal (10, 24), we measured the levels of the phosphorylated forms of these proteins in the presence or absence of Cripto knockdown. We found that SMAD2 is constitutively phosphorylated in control embryos ( Fig. 2A) and that Cripto depletion in trophectoderm cells substantially reduced this basal level of SMAD2 activation (Fig. 2B) . Similarly, the expression of the Cripto shRNA in the trophectoderm reduced the level of the phosphorylated, active forms of SRC (Fig. 2D) and ERK (Fig. 2F) , whereas the control virus lacking shRNA expression did not (Fig. 2C and 2E) . Finally, depletion of Cripto in trophoblast cells also reduced the phosphorylation of AKT as compared with control ( Fig. 2H and  2G ). These data suggest that Cripto is required for the activation of these signaling proteins and that its loss has a significant impact on their signaling status.
Targeted depletion of Cripto in trophoblast cells disrupts embryo attachment
Next, we transferred embryos derived from Cripto knockdown trophoblasts into uteri of foster mothers. Although no difference was found between the total number of implantation sites counted in females with control embryos and females carrying Cripto-depleted embryos (Fig. 3A) , the number of Cripto knockdown embryos flushed from the uteri on E4.5 was significantly higher than that of control embryos (Fig. 3B) , indicating loose attachment of the Cripto-null embryo to the uterine wall. A role for Cripto in promoting embryo attachment agrees with our observation that osteopontin, a key player in the contact of the embryo with the endometrium (25) , is downregulated at implantation sites of embryos with Cripto depletion (Fig. 3C) . Implantation sites of Cripto-depleted embryos also expressed lower levels of additional genes essential for embryo attachment, such as heparin-binding epidermal growth factor-like growth factor (HbEGF) and the integrins Itgav, Itgb1, and Itgb3 (Fig. 3D) .
Depletion of Cripto in trophoblast cells causes impaired embryo development and abnormal implantation site formation
Early E4.5 preimplanted Cripto knockdown and control embryos did not differ in their gross morphology (Supplemental Fig. 1C) . Nevertheless, histological examination of implantation sites (late E4.5) revealed that Cripto-depleted embryos lack the implantation chamber ( Fig. 4Ad and 4Ae ) that is clearly present in control embryos (Fig. 4Aa and 4Ab) . Additionally, whereas the implanted control embryos exhibited normal inner cell mass (ICM) and trophoblast cells (Fig. 4Ac) , the Criptodepleted embryos appeared smaller with no clear lineage differentiation into trophoblast cells and ICM (Fig. 4Af) . The inappropriate postimplantation development of Cripto knockdown blastocysts was accompanied by reduced embryonic cell proliferation, as visualized by immunostaining with Ki67 (Fig. 4B) . Additionally, TUNEL staining revealed that Cripto depletion induced a high level of apoptosis in trophoblast cells (Fig. 4C) .
The impaired attachment of the Cripto-depleted embryos resulted in the formation of abnormally enlarged implantation sites ( Fig. 5; Supplemental Fig. 2 ) associated with elevated decidual cell proliferation (Fig. 4B ) and upregulated expression of decidualization-associated genes (Fig. 6A) . A previous study demonstrated that phosphorylation of AKT is reduced and FOXO1 expression is upregulated during decidualization (26) . Indeed, we found that phosphorylation levels of AKT in implantation sites formed in the presence of Criptodepleted trophoblast cell embryos were reduced as compared with implantation sites harboring control embryos consistent with a decidualization phenotype (Fig. 6Ba and 6Bc) . Consistently, we also observe upregulation of FOXO1 expression in Cripto-depleted trophoblast cells as compared with control cells (Fig. 6Bb  and 6Bd) .
Examination of uterine histological sections also revealed an abnormally low number of microvessels in implantation sites of Cripto knockdown embryos (Fig. 7Ac/7Ad and 7Aa/7Ab, respectively; Supplemental Fig. 2; Supplemental Movies 1 and 2) . The reduced number of microvessels could possibly be attributed to the lower abundance of smooth muscle actin (Fig. 7B) and vascular endothelial growth factor (VEGF)-A in the Cripto-depleted embryo implantation sites (Supplemental Fig. 3 ).
Cripto blocking agents inhibit attachment of trophoblastic spheroids to endometrial cell monolayers in vitro
The role of Cripto in embryo attachment was further supported by in vitro experiments using trophoblastic choriocarcinoma Jeg-3 cells (Supplemental Fig. 4A) . Specifically, the addition of soluble, recombinant Cripto protein to the incubation medium promoted attachment of Jeg3-derived trophoblastic spheroids to monolayers of Ishikawa endometrial cells (Supplemental Fig. 4A ). This effect was inhibited by treatment with a Cripto-specific antagonist, ALK4-Fc (14) (Supplemental Fig. 4B) . As mentioned previously, we previously identified GRP78 as a Cripto-binding protein and signaling mediator (12, 13) . In those studies we demonstrated that a GRP78 neutralizing antibody disrupts Cripto/GRP78 binding and blocks Cripto signaling. Consistently, we show in the present study that treatment with this GRP78 neutralizing antibody reduced Jeg-3 spheroid attachment to endometrial cells (Supplemental Fig. 4C ). These results with Cripto-blocking agents corroborate our knockdown studies and further implicate Cripto as a key embryo attachment factor. The effects of the GRP78 neutralizing antibody also implicate this protein as a Cripto signaling partner in embryo attachment.
Cripto and its signaling partner GRP78 have overlapping expression patterns at sites of embryo implantation
We compared the expression patterns of Cripto and GRP78 in pregnant mouse uterus and found that GRP78 and Cripto are highly expressed in the same cells and areas as on E4.5 ( Fig. 8a-8d) , E5.5, and E6.5 of pregnancy (Fig. 8g/8h and 8j, respectively) . On E6.5, both Cripto and GRP78 are expressed in the ectoplacental cone, consisting of cytotrophoblast cells, which will form the placenta at later pregnancy ( Fig. 8i and 8j, respectively) . The overlapping localization of Cripto and GRP78 is consistent with the ability of the GRP78 neutralizing antibody to block attachment of Jeg-3 spheroids to endometrial cells and further suggests a role for GRP78 in mediating Cripto signaling during embryo attachment.
Discussion
In this study we investigated the role of Cripto expression in trophoblast cells during embryo implantation. Our results demonstrate that depletion of Cripto in trophoblast cells causes impaired implantation and inappropriate embryonic development. The lentiviral shRNA delivery method we used addresses the need for a placenta-specific gene knockdown system for elucidating the molecular basis of placental development and function. This approach is especially required in circumstances such as those in the present study because complete knockout of Cripto expression leads to an early embryonic lethal phenotype (2). Criptonull embryos mostly consist of anterior neuroectoderm and lack posterior structures, thus resembling a head without a trunk. Additionally, genes responsible for head organization are located at the distal end of the embryo, whereas marker genes of the primitive streak are absent or localized to the proximal side. This study explored the role of Cripto expression only from E5.5 (1 day after implantation) and did not examine the effect of complete loss of Cripto expression on embryo implantation. Cripto-null embryos were recovered in the expected Mendelian ratios at 6.75 days after conception and no homozygous Cripto-null embryos were obtained after 10.5 days after conception, suggesting that those embryos were absorbed (2). Our results suggest that the deletion of Cripto in the trophoblast cells is already sufficient to cause defects in embryonal development by impairing normal embryo attachment.
We have provided evidence indicating that the expression of Cripto in trophoblast cells is necessary for normal embryo implantation and survival at early days of pregnancy. Previous knockout studies have demonstrated that Cripto is essential for organ development and patterning during embryogenesis in the mouse (16) . Our results identify a novel role for Cripto, demonstrating that this protein, specifically produced by the trophoblast cells, is also crucial for embryo attachment to the uterus during the very early stage of pregnancy.
Cripto is known to modulate signaling via multiple pathways, including SMAD2, SRC, ERK1/2, and AKT (15), and we have shown that Cripto knockdown in trophoblast cells reduces the level of the active phosphorylated form of each of these downstream signaling mediators. These findings are consistent with previous reports of the involvement of these signaling molecules in regulating pregnancy-associated events. The SRC family has been shown to regulate normal placentogenesis and endometrium decidualization (27) (28) (29) . Additionally, both MAPK and PI3K/Akt play important roles in glucose transport and regulation of blastocyst survival (30, 31) , endometrial cell migration (32) , invasiveness of trophoblasts cells in human early pregnancy (33) , and the induction of metalloproteinase-2 and VEGF expression in human trophoblast cells (34) . SMAD2 has been also No abnormal implantation sites were found in uterine tissue with shControl embryos at E4.5, whereas an average of 2.5 abnormal implantation sites were detected in females transplanted with shCripto embryos (n = 7 females with control embryos and 10 females with Cripto knockdown embryos, total normal implantation sites = 33 in shControl and 18 in shCripto embryos; abnormal implantation sites = 0 in shControl and 25 in shCripto). (B) Uterine tissue isolated at E4.5 from females implanted with shCripto-infected embryos exhibits fewer normal implantation sites as compared with mice harboring shControl-infected embryos (4.7 6 0.5 normal implantation sites in control vs 1.8 6 0.5 in shCripto; n = 7 control females and 10 Cripto females.). (C) Representative uteri isolated at E4.5. Females were injected in the tail vein with Evans blue and then euthanized. Uteri were isolated and the number of normal and abnormal implantation sites was determined. Straight arrows point to normal implantation sites, dashed arrows point to abnormal implantation sites, and dot arrow points to absorption site. (D) Quantification of implantation site size (n = 6 control and n = 14 shCripto; implantation sites from at least six animals).
heavily implicated in early embryogenesis and was detected in rat and mouse endometrium during the course of the estrous cycle as well as at the time of periimplantation (35, 36) . Additionally, a recent study found that maternal SMAD3 deficiency compromises decidualization in mice (37) .
We have demonstrated that while the number of implantation sites does not appear to be affected, Cripto knockdown in trophoblast cells interferes with normal embryo attachment to the uterus. The implantation sites of Cripto-depleted embryos exhibit abnormal size and, consistently, have increased proliferation of decidua cells and elevated expression of genes involved in decidualization, such as LIF and WNT4. We further detected lower phosphorylation levels of AKT and elevated expression levels of FOXO1 in abnormal implantation sites of embryos derived from Cripto knockdown trophoblast cells as compared with those from control cells. Both reduction in AKT phosphorylation and upregulation of FOXO1 expression have been implicated in the decidualization process (26) . Taken together, these results suggest that loss of Cripto and the resulting impairment of implantation stimulate the decidualization process. These phenotypes are consistent with the fact that Cripto-depleted embryos frequently do not survive. A role for embryonic molecular signals in the proper decidualization process has been suggested by previous studies demonstrating that normal decidua formation is disrupted in the absence of the embryo (38) .
Targeted depletion of Cripto in trophoblast cells further resulted in reduced formation of microvessels in the implantation sites. This observation agrees with the previous observation that Cripto promotes human umbilical vein endothelial cell differentiation into vascular-like structures (39) . It was shown that treatment with soluble Cripto protein induced microvessel formation and that this effect was significantly inhibited by a Cripto-blocking monoclonal antibody (39) . Also, tumors formed by Cripto-transfected MCF-7 cells in the mammary fat pad of nude mice had higher microvessel density than did tumors resulting from control cells (39) . Our work indicates that Cripto may also promote angiogenesis during embryo implantation and early placenta formation. As mentioned previously, activation of the Cripto downstream affecters PI3K/Akt and ERK1/2 induces VEGF expression in human trophoblast cells (34) . Cripto is strongly associated with the mesenchymal phenotype and induces smooth muscle actin expression in multiple contexts, including mammary gland tumors (40) . We observed reduced shCripto infected trophoblast-derived embryos. Implantation sites were fixed in PFA and then sectioned and recorded in the HREM (n = 3 control or shCripto implantation sites from three animals). Embryos are marked in blue and with arrow. In (b), rectangles surround a representative area rich with microvessels. ***P , 0.001. (B) Control implantation sites exhibit positive staining of smooth muscle actin in cells surrounding blood vessels (n = 3 control or shCripto implantation sites recovered from three animals). Implantation sites of Cripto-depleted embryos exhibit undetectable staining of smooth muscle actin in implantation sites. Note the lack of blood vessels in this implantation site. Arrows indicate positive staining of smooth muscle actin around blood vessels (n = 3 control or shCripto implantation sites from three animals). A, artery; E, embryo; M, myometrium; UL, uterine lumen.
expression of smooth muscle actin in implantation sites of embryos with Cripto depletion in their trophoblast cells. The reduced phosphorylation of ERK1/2 we observed in Cripto-depleted trophoblast cells might lead to reduced expression of VEGF-A and lower levels of smooth muscle actin, resulting in attenuated formation of microvessels at implantation sites.
GRP78 was previously identified as a Cripto-binding protein and signaling partner (12, 13) . Our results in the present study suggest that Cripto effects on embryo attachment are mediated by its binding to GRP78. The interaction of GRP78 and Cripto at the cell surface is required for Cripto signaling via the TGF-b and SRC/ MAPK/PI3K pathways (4, 12, 14) . As mentioned previously, each of these pathways plays key roles in embryo implantation. GRP78 is also required during the peri-implantation stage in mice, as GRP78 2/2 embryos display massive apoptosis of inner cell mass cells and die at approximately E3.5 (41) . Additionally, GRP78 is highly expressed in human first trimester cytrophoblastic cells and has been shown to play an important role in syncytialization (42) . Dysregulation of GRP78 expression or localization might also be involved in pregnancy complications such as preeclampsia (42, 43) . Taken together with these studies, our results suggest a possible collaborative role for Cripto and GRP78 in normal embryo implantation and attachment. Previous studies demonstrated that targeting Cripto with either Alk4-Fc or a neutralizing GRP78 Ab is sufficient to block Cripto signaling and biological effects (12, 14) . Our data showing that Cripto and GRP78 colocalize at implantation sites together with our demonstration that a GRP78 neutralizing antibody inhibits attachment of trophoblast-derived spheroids to endometrial cells suggest that Cripto promotes embryo attachment via its interaction with GRP78. Future studies will examine whether artificially enhancing Cripto/GRP78 signaling can increase the embryo implantation rate.
In conclusion, embryo-maternal recognition and embryo implantation are precisely regulated processes involving many embryonic and maternal genes and factors. Identification of Cripto as a key embryoderived factor will facilitate our understanding of the mechanisms of embryo implantation and could lead to the development of novel strategies for treatment of infertility.
